DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United Arab Emirates
  • /
  • Materials
Published
09 Feb 25
Updated
04 Jun 26
Views
159
Not Invested
FertiglobeFERTIGLB
FERTIGLB logo
Fair Value
د.إ3.58
Share price04 Jun
د.إ2.5827.9% undervalued intrinsic discount
Loading
1Y4.45%
7D-2.64%

Emerging Demand And Green Ammonia Will Foster Future Potential

AN
AnalystConsensusTarget
AnalystConsensusTarget

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
09 Feb 25
Updated
04 Jun 26
Views
159
Not Invested
Fair Valueد.إ3.58
Share priceد.إ2.58
27.9% undervalued intrinsic discount
Narrative
Updates14

Last Update 04 Jun 26

Fair value Decreased 0.0055%

FERTIGLB: Future Dividend Cash Flows Will Support Attractive Payout-Led Upside Potential

Analysts have adjusted their AED fair value estimate for Fertiglobe slightly lower to AED 3.58, reflecting updated assumptions that point to a smaller decline in revenue growth, a modestly stronger profit margin, and a lower future P/E multiple.

What's in the News

  • A board meeting is scheduled for 28 April 2026 at 13:00 UTC to review and approve Fertiglobe's first quarter 2026 financial statements and to discuss general company activities and projects. (Source: Company event filing)
  • A cash dividend for the second half of 2025 has been approved at US$135 million, equivalent to AED 496 million or 6.05 fils per share. (Source: Company announcement)
  • The total cash dividend for the full year 2025 is set at US$260 million, equivalent to AED 955 million or 11.64 fils per share, with payment expected within 30 days from 9 March 2026. (Source: Company announcement)
  • Key dividend dates include the ex dividend date on 18 March 2026, the last entitlement date on 17 March 2026, and the shareholders registry closing date on 23 March 2026. (Source: Company announcement)

Valuation Changes

  • Fair Value: AED 3.58 in the previous model to AED 3.58 in the updated model, a very small downward adjustment.
  • Discount Rate: risen slightly from 19.69% to 19.78%, indicating a marginally higher required return in the model.
  • Revenue Growth: the projected annual revenue change has improved from a decline of 2.76% to a smaller decline of 1.99%.
  • Net Profit Margin: edged higher from 13.37% to 13.71%, pointing to a modestly stronger profitability assumption.
  • Future P/E: eased from 35.06x to 33.45x, implying a lower valuation multiple applied to future earnings in the model.
Read more
16 viewsusers have viewed this narrative update

Key Takeaways

  • Strategic positioning in key markets, supply advantages, and operational improvements are strengthening Fertiglobe's pricing power, margins, and long-term earnings potential.
  • Investments in low-carbon ammonia and strategic partnerships enable Fertiglobe to capitalize on emerging markets and diversify high-margin revenue streams.
  • Reliance on traditional products, energy price volatility, gas supply risks, and delayed sustainability investments heighten Fertiglobe's long-term revenue and margin vulnerabilities.

Catalysts

About Fertiglobe
    Produces and sells nitrogen-based products in Europe, North and South America, Africa, the Middle East, Asia, and Oceania.
What are the underlying business or industry changes driving this perspective?
  • Strengthening global food demand, particularly from emerging markets like India, is driving higher fertilizer consumption, as seen in robust tender activity and record urea pricing; this positions Fertiglobe to benefit from sustained volume and pricing power, supporting long-term revenue and earnings growth.
  • Tightening international trade restrictions (e.g., EU tariffs on Russian fertilizers) and supply constraints (including limited Chinese exports and regional outages) are reducing competitive pressure in key markets where Fertiglobe enjoys duty-free access, translating into improved pricing, protected market share, and increased net margins.
  • Fertiglobe's ongoing manufacturing improvements-driving higher plant utilization, energy efficiency, and reduced non-gas costs-are expected to increase own-produced sales volumes and expand EBITDA margins over the next several years, directly enhancing earnings and free cash flow.
  • Investments in low-carbon and green ammonia (e.g., Project Harvest and pipeline projects), along with established strategic partnerships, position Fertiglobe to capture emerging demand from new applications such as hydrogen transport and marine fuels, creating optionality for new high-margin revenue streams as the sustainable ammonia market matures.
  • Structural cost advantages from secured long-term gas contracts (especially in Egypt) and integration with ADNOC allow Fertiglobe to mitigate feedstock volatility, maintain price competitiveness, and support dividend sustainability and free cash flow conversion versus higher-cost global peers.
Fertiglobe Earnings and Revenue Growth

Fertiglobe Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Fertiglobe's revenue will decrease by 2.0% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 18.3% today to 13.7% in 3 years time.
  • Analysts expect earnings to reach $393.3 million (and earnings per share of $0.05) by about June 2029, down from $559.2 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $617.5 million in earnings, and the most bearish expecting $234.7 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 33.5x on those 2029 earnings, up from 12.0x today. This future PE is greater than the current PE for the AE Chemicals industry at 16.7x.
  • Analysts expect the number of shares outstanding to decline by 1.33% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 19.78%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Fertiglobe's operations remain significantly exposed to external gas supply disruptions in Egypt and unresolved gas contract negotiations in Algeria, creating ongoing volume volatility, supply chain risk, and potential downward pressure on revenue and earnings.
  • The company has delayed FID on major low-carbon/ammonia projects (e.g., Rabdan, Baytown), reflecting uncertainty about regulatory frameworks, market readiness, and the ability to profit from the industry shift toward sustainability, which could limit long-term revenue growth if global ammonia markets decarbonize faster than Fertiglobe's pace of investment.
  • Heavy reliance on traditional urea and ammonia sales exposes Fertiglobe to secular risks if the global market shifts substantially toward organic/regenerative agriculture, biologicals, or alternative crop nutrition technologies, potentially shrinking the medium/long-term addressable market and reducing future revenues and margins.
  • While Fertiglobe benefits currently from tariffs on Russian and Belarusian fertilizer imports into the EU, this advantage could erode if other low-cost producers enter the market, tariff regimes change, or price-driven demand destruction materializes at elevated urea/ammonia prices-introducing longer-term risks to revenue stability.
  • Structural dependence on natural gas feedstock subjects Fertiglobe to persistent volatility in energy prices, which-when coupled with intensifying global decarbonization policies and potentially higher carbon pricing-could compress net margins, require rising capex for environmental compliance, and reduce overall profitability over time.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of AED3.58 for Fertiglobe based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of AED4.4, and the most bearish reporting a price target of just AED2.9.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $2.9 billion, earnings will come to $393.3 million, and it would be trading on a PE ratio of 33.5x, assuming you use a discount rate of 19.8%.
  • Given the current share price of AED3.0, the analyst price target of AED3.58 is 16.1% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Fertiglobe?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

1 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

FERTIGLB logo
Fertiglobe
8.5% undervalued intrinsic discount

Bearish View Expects Margin Compression As Tight Nitrogen Markets Eventually Loosen

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 13 Aug
Read Narrative
FERTIGLB logo
Fertiglobe
38.5% undervalued intrinsic discount

Tight Nitrogen Markets And Cost Efficiencies Will Support Stronger Future Earnings Power

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 14 Jul
Read Narrative

Fair Value vs Share Price

د.إ3.58
vs د.إ2.5827.9% undervalued intrinsic discount
PastFuture05b2018202020222024202620282029Revenue US$2.9bEarnings US$393.3m
-2%
Revenue growth
13.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Fertiglobe

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Very undervalued with solid track record.

Market capد.إ21.1b
PB3.8x
Estimated Growth-5.5%
Dividend Yield4.4%
Full analysis

CEO & management

Ahmed El-Hoshy
CEO
5.7yrs
CEO Tenure

Produces and sells nitrogen-based products in Europe, North and South America, Africa, the Middle East, Asia, and Oceania.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide